A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through σ1 receptors

European Journal of Pharmacology

Volumn 536, Issue 1-2, 2006, Pages 200-203

  Bucolo, Claudio ^a   Marrazzo, Agostino ^a   Ronsisvalle, Simone ^a   Ronsisvalle, Giuseppe ^a   Cuzzocrea, Salvatore ^b   Mazzon, Emanuela ^b   Caputi, Achille ^b   Drago, Filippo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

1 receptors; Adamantane derivative; Ischemia; Neuroprotection; Retina

Indexed keywords

[[1 ADAMANTYL(METHYL)AMINO]METHYL] 1 PHENYLCYCLOPROPANECARBOXYLATE; ADAMANTANE DERIVATIVE; ADENOSINE TRIPHOSPHATE; ESTRADIOL; GLUCOSE; LACTIC ACID; MR 22; NEUROPROTECTIVE AGENT; PRASTERONE SULFATE; RECEPTOR BLOCKING AGENT; SIGMA 1 OPIATE RECEPTOR; SIGMA 1 RECEPTOR AGONIST; SIGMA 1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR AFFINITY; REPERFUSION INJURY; RETINA; RETINA DEGENERATION; RETINA ISCHEMIA;

ADAMANTANE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANISOLES; GLUCOSE; LACTIC ACID; MALE; PROPYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; REPERFUSION INJURY; RETINA; RETINAL DISEASES;

EID: 33645813569     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.02.026     Document Type: Article

References (32)

1. Brent P.J., Saunders H., and Dunkley P.R. Intrasynaptosomal free calcium levels in rat forebrain synaptosomes: Modulation by sigma (σ) receptor ligands. Neurosci. Lett. 211 (1996) 138-142
2. 1 recognition sites. Eur. J. Pharmacol. 498 (2004) 111-114
3. 1-site agonists lower intraocular pressure. J. Pharmacol. Exp. Ther. 289 (1999) 1362-1369
4. Bucolo C., Drago F., Lin L.R., and Reddy V.N. Neuroactive steroids protect retinal pigment epithelium against oxidative stress. NeuroReport 16 (2005) 1203-1207
5. Campbell B.G., Bobker D.H., Leslie F.M., Mefford I.N., and Weber E. Both the σ receptor-specific ligand (+)3-PPP and the PCP receptor-specific ligand TCP act in the mouse vas deferens via augmentation of electrically evoked norepinephrine release. Eur. J. Pharmacol. 138 (1987) 447-449
6. Campbell B.G., Scherz M.W., Keanna J.F.W., and Weber E. Sigma receptors inhibit contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation elicited by both electrical stimulation and exogenous serotonin. J. Neurosci. 9 (1989) 3380-3391
7. 2 sites. Neurosci. Res. Commun. 14 (1994) 43-51
8. Drago F., Valzelli S., Emmi I., Marino A., Cassar Scalia C., and Marino V. Latanoprost exerts Neuroprotective activity in vitro and in vivo. Exp. Eye Res. 72 (2001) 479-486
9. Gonzalez-Alvear G.M., and Werling L.L. Sigma receptor regulation of norepinephrine release from rat hippocampal slices. Brian Res. 673 (1995) 61-69
10. 1 receptor agonist. Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 455-461
11. Kennedy C., Jarvis G.E., and Henderson G. The ligand rimcazole antagonizes (+)SKF10,047, but not (+)3-PPP, in the mouse isolated vas deferens. Eur. J. Pharmacol. 181 (1990) 315-318
12. 2 binding in rat brain. Eur. J. Pharmacol. 259 (1994) 65-69
13. 1 binding site. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 8072-8077
14. Hayashi T., and Su T.P. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 491-496
15. 2+ concentration. J. Pharmacol. Exp. Ther. 293 (2000) 788-789
16. Marrazzo A., Prezzavento O., Pasquinucci L., Vittorio F., and Ronsisvalle G. Synthesis and pharmacological evaluation of potent and enantioselective sigma 1 and sigma 2 ligands. Farmaco 56 (2001) 181-189
17. 2 binding sites. Farmaco 57 (2002) 45-53
18. Marrazzo A., Caraci F., Salinaro E.T., Su T.P., Copani A., and Ronsisvalle G. Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity. NeuroReport 16 (2005) 1223-1226
19. Mei J., and Pasternak G.W. Molecular cloning and pharmacological characterization of the rat sigma1 receptor. Biochem. Pharmacol. 62 (2001) 349-355
20. Monnet F.P., De Costa B.R., and Bowen W.D. Differentiation of (ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. Br. J. Pharmacol. 119 (1996) 65-72
21. Moore-Martin P.M., Ola M.S., Agarwal N., Ganapathy V., and Smith S.B. The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate. Mol. Brain Res. 123 (2004) 66-75
22. Nakazato A., Kumagai T., Otha K., Chaki S., Okuyama S., and Tomisawa K. Synthesis and SAR of 1-alkyl-2-phenylethylamine derivatives designed from N,N-dipropyl-4-methoxy-3-(2-phenylethoxy) phenylethylamine to discover sigma(1) ligands. J. Med. Chem. 42 (1999) 3965-3970
23. 1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures. Neurochem. Int. 32 (1998) 337-343
24. Okuyama S., Imagawa Y., Ogawa S., Araki H., Ajima A., Tanaka M., Maramatsu M., Nakazato A., Yamaguchi K., Yoshida M., and Otomo S. NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci. 53 (1993) 285-290
25. Ola M.S., Moore P., El-Sherbeny A., Roon P., Agarwal N., Sarthy V.P., Casellass P., Ganapathy V., and Smith S.B. Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. Mol. Brain Res. 95 (2001) 86-95
26. Quiron R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., and Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13 (1992) 85-86
27. Schoenwald R.D., Barfknecht C.F., Xia E., and Newton R.E. The presence of σ receptors in the lacrimal gland. J. Ocul. Pharmacol. 9 (1993) 125-139
28. Senda T., Matsuno K., Okamoto K., Kobayashi T., Nakata K., and Mita S. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur. J. Pharmacol. 315 (1996) 1-10
29. Senda T., Matsuno K., and Mita S. The presence of sigma receptor subtypes in bovine retinal membranes. Exp. Eye Res. 64 (1997) 857-860
30. 1 receptor agonist glutamate neurotoxicity in cultured rat retinal neurons. Eur. J. Pharmacol. 342 (1998) 105-111
31. Tanaka M., Shirasaki T., Kaku S., Muramatsu M., and Otomo S. Characteristics of binding of [3H]NE-100, a novel sigma receptor ligand, to guinea pig brain membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 351 (1995) 244-251
32. Wang W.F., Ishiwata K., Kiyosawa M., Kawamura K., Oda K., Kobayashi T., Matsuno K., and Mochizuchi M. Visualization of sigma1 receptors in eyes by ex vivo autoradiography and in vivo positron emission tomography. Exp. Eye Res. 75 (2002) 723-730